Orc Software AB -- Year-End Financial Report January 1 -- December 31, 2004
January 26, 2005 02:50 ET | Orc Software
STOCKHOLM, Sweden, Jan. 26, 2005 (PRIMEZONE) -- Orc Software AB: -- Revenue for 2004 decreased by 1 percent and amounted to SEK 247 (249) million. -- Operating income for 2004 decreased by...
Yara styrker posisjo
Yara styrker posisjon innen spesialgjødsel
January 26, 2005 02:29 ET | Yara International ASA
Yara har siden 2001 hatt en global markedsføringsavtale med spesialgjødsel-selskapet SQM. Samarbeidet har vært en suksess for begge parter. Siden 2002 har Yara også hatt et indirekte eierskap i SQM...
Yara strengthens pos
Yara strengthens position in specialty fertilizer
January 26, 2005 02:29 ET | Yara International ASA
Since 2001 Yara has had a global marketing agreement with Chilean specialty fertilizer company SQM, which has been very successful for both parties. Since 2002 Yara has also been an indirect owner of...
nokialogo.png
Nokia toimittaa verkkolaajennuksen Ethiopian Telecommunication Corporationille Etiopiaan
January 26, 2005 02:14 ET | Nokia Oyj
Sopimuksen arvo on noin 23 miljoonaa euroa   Ethiopian Telecommunications Corporation (ETC) on valinnut Nokian toimittamaan sen GSM/GPRS-verkkolaajennuksen. Sopimuksen arvo on noin 23 miljoonaa...
Telelogic
Telelogic Year-end report 2004
January 26, 2005 02:06 ET | Telelogic
MALMO, Sweden, Jan. 26, 2005 (PRIMEZONE) -- Telelogic Year end report 2004 * 24.4% operating margin during fourth quarter * 20% revenue growth in local currency during fourth quarter * Telecom...
NOVARTIS logo.jpg
Les premiers résultats d'une étude de grande envergure révèlent que Femara® apporte un bénéfice plus important en termes de survie en période de rémission, comparativement au tamoxifène, en traitement adjuvant du cancer du sein à un stade précoce.
January 26, 2005 02:00 ET | Novartis Pharma AG
Les premiers résultats d'une étude de grande envergure révèlent que Femara® apporte un bénéfice plus important en termes de survie en période de rémission, comparativement au tamoxifène, en traitement...
NOVARTIS logo.jpg
Erste Ergebnisse einer grossen Studie belegen bessere Chancen für ein krankheitsfreies Überleben bei Brustkrebs im Frühstadium mit Femara® als adjuvanter Therapie im Vergleich mit Tamoxifen
January 26, 2005 02:00 ET | Novartis Pharma AG
Die Daten zeigen bereits nach 26 Monaten für alle postmenopausalen Frauen mit hormonrezeptorpositivem Brustkrebs im Frühstadium (19%, p=0,003) deutlich bessere Chancen für ein krankheitsfreies...
nokialogo.png
Nokia wins 23 million euro network expansion deal from Ethiopian Telecommunications Corporation
January 26, 2005 01:56 ET | Nokia Oyj
Espoo, Finland - Ethiopian Telecommunications Corporation (ETC) has selected Nokia to further expand its GSM and GPRS network, reinforcing Nokia as one of the leading network suppliers to ETC. ...
Precision Castparts
Precision Castparts Corp. Enhances Aerospace Fastener Capabilities by Acquiring Air Industries Corporation
January 25, 2005 20:36 ET | Precision Castparts Corp.
PORTLAND, Ore., Jan. 25, 2005 (PRIMEZONE) -- Precision Castparts Corp. (NYSE:PCP) has entered into definitive agreements to acquire the shares of Air Industries Corporation (AIC) and the assets of...
Squitieri & Fearon, LLP Announces Lawsuit Against American Business Financial Services, Inc. -- ABFI
January 25, 2005 19:45 ET | Squitieri & Fearon, LLP
NEW YORK, Jan. 25, 2005 (PRIMEZONE) -- The following statement was issued today by Squitieri & Fearon, LLP. YOU ARE HEREBY NOTIFIED that a Class Action has been filed in the United States...